AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins
Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 ( Prph2 , also known as peripherin/RDS) is an abundantly expressed photoreceptor-...
Gespeichert in:
Veröffentlicht in: | Gene therapy 2010-04, Vol.17 (4), p.486-493 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 493 |
---|---|
container_issue | 4 |
container_start_page | 486 |
container_title | Gene therapy |
container_volume | 17 |
creator | Georgiadis, A Tschernutter, M Bainbridge, J W B Robbie, S J McIntosh, J Nathwani, A C Smith, A J Ali, R R |
description | Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 (
Prph2
, also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence
Prph2
in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence
Prph2 in vivo
as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies. |
doi_str_mv | 10.1038/gt.2009.162 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_746306935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A224168240</galeid><sourcerecordid>A224168240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c611t-97e8e736a980f705c53133f36cde91589601cef59e38693b33dc3a7042e0423b3</originalsourceid><addsrcrecordid>eNqF0tuL1DAUB-AiijuuPvkuRXFFtGNuTZrHsngZWFTWy2vIpGknu20yJu2u_veeYUbHkRUJTWj7nRwSfln2EKM5RrR61Y1zgpCcY05uZTPMBC9KxsntbIYkl4XApDrK7qV0gRBioiJ3syPwGHHCZ9mirr8Wg22cHm2TX_pgLptw7fPQ5h9tdOsVTL4gufP5lbsK-ZSc7_LBnb-vi6VOULPSLq6dT_ezO63uk32wW4-zL29efz59V5x9eLs4rc8KwzEeCylsZQXlWlaoFag0JcWUtpSbxkpcVpIjbGxbSksrLumS0sZQLRAjFh54P86ebfddx_BtsmlUg0vG9r32NkxJCcYpgsry_5JCixIRDvLJX_IiTNHDMRThjHFWIilBPf6nwpXAjFdiv1Wne6ucb8MYtdk0VjUhDPOKMARqfoOC0djBmeBt6-D7QcHzgwIwo_0-dnpKSS0-nR_akz_syup-XKXQT6MLPh3CF1toYkgp2latoxt0_KEwUptsqW5Um2wpyBboR7vjT0tIzG_7K0wAnu6ATkb3bdTeuLR3pOQYLhLcy61L8Mt3Nu7v8aa-PwE5wNzN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218714687</pqid></control><display><type>article</type><title>AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Georgiadis, A ; Tschernutter, M ; Bainbridge, J W B ; Robbie, S J ; McIntosh, J ; Nathwani, A C ; Smith, A J ; Ali, R R</creator><creatorcontrib>Georgiadis, A ; Tschernutter, M ; Bainbridge, J W B ; Robbie, S J ; McIntosh, J ; Nathwani, A C ; Smith, A J ; Ali, R R</creatorcontrib><description>Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 (
Prph2
, also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence
Prph2
in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence
Prph2 in vivo
as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies.</description><identifier>ISSN: 0969-7128</identifier><identifier>EISSN: 1476-5462</identifier><identifier>DOI: 10.1038/gt.2009.162</identifier><identifier>PMID: 20010626</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Alleles ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Applied cell therapy and gene therapy ; Base Pairing ; Base Sequence ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Biotechnology ; Blotting, Western ; Care and treatment ; Cell Biology ; Cellular biology ; Dependovirus ; Dependoviruses ; Development and progression ; DNA Primers - genetics ; Fundamental and applied biological sciences. Psychology ; Gene Expression ; Gene silencing ; Gene Therapy ; Genetic aspects ; Genetic Therapy - methods ; Health aspects ; Health. Pharmaceutical industry ; Human Genetics ; Immunohistochemistry ; Industrial applications and implications. Economical aspects ; Intermediate Filament Proteins - genetics ; Medical sciences ; Membrane Glycoproteins - genetics ; Methods ; Mice ; MicroRNAs ; MicroRNAs - genetics ; miRNA ; Molecular Sequence Data ; Mutation ; Nanotechnology ; Nerve Tissue Proteins - genetics ; original-article ; Peripherin ; Peripherins ; Photoreceptors ; Physiological aspects ; Properties ; Retina ; Retinal degeneration ; Retinal Degeneration - genetics ; Retinal Degeneration - therapy ; Retinal diseases ; Retinitis ; Retinitis pigmentosa ; Reverse Transcriptase Polymerase Chain Reaction ; Ribonucleic acid ; RNA ; RNA Interference ; RNA-mediated interference ; Synthesis ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Gene therapy, 2010-04, Vol.17 (4), p.486-493</ispartof><rights>Macmillan Publishers Limited 2010</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2010 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Apr 2010</rights><rights>Macmillan Publishers Limited 2010.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c611t-97e8e736a980f705c53133f36cde91589601cef59e38693b33dc3a7042e0423b3</citedby><cites>FETCH-LOGICAL-c611t-97e8e736a980f705c53133f36cde91589601cef59e38693b33dc3a7042e0423b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22561509$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20010626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Georgiadis, A</creatorcontrib><creatorcontrib>Tschernutter, M</creatorcontrib><creatorcontrib>Bainbridge, J W B</creatorcontrib><creatorcontrib>Robbie, S J</creatorcontrib><creatorcontrib>McIntosh, J</creatorcontrib><creatorcontrib>Nathwani, A C</creatorcontrib><creatorcontrib>Smith, A J</creatorcontrib><creatorcontrib>Ali, R R</creatorcontrib><title>AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins</title><title>Gene therapy</title><addtitle>Gene Ther</addtitle><addtitle>Gene Ther</addtitle><description>Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 (
Prph2
, also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence
Prph2
in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence
Prph2 in vivo
as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies.</description><subject>Alleles</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Applied cell therapy and gene therapy</subject><subject>Base Pairing</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Blotting, Western</subject><subject>Care and treatment</subject><subject>Cell Biology</subject><subject>Cellular biology</subject><subject>Dependovirus</subject><subject>Dependoviruses</subject><subject>Development and progression</subject><subject>DNA Primers - genetics</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression</subject><subject>Gene silencing</subject><subject>Gene Therapy</subject><subject>Genetic aspects</subject><subject>Genetic Therapy - methods</subject><subject>Health aspects</subject><subject>Health. Pharmaceutical industry</subject><subject>Human Genetics</subject><subject>Immunohistochemistry</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Intermediate Filament Proteins - genetics</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Methods</subject><subject>Mice</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>miRNA</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Nanotechnology</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>original-article</subject><subject>Peripherin</subject><subject>Peripherins</subject><subject>Photoreceptors</subject><subject>Physiological aspects</subject><subject>Properties</subject><subject>Retina</subject><subject>Retinal degeneration</subject><subject>Retinal Degeneration - genetics</subject><subject>Retinal Degeneration - therapy</subject><subject>Retinal diseases</subject><subject>Retinitis</subject><subject>Retinitis pigmentosa</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA Interference</subject><subject>RNA-mediated interference</subject><subject>Synthesis</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0969-7128</issn><issn>1476-5462</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqF0tuL1DAUB-AiijuuPvkuRXFFtGNuTZrHsngZWFTWy2vIpGknu20yJu2u_veeYUbHkRUJTWj7nRwSfln2EKM5RrR61Y1zgpCcY05uZTPMBC9KxsntbIYkl4XApDrK7qV0gRBioiJ3syPwGHHCZ9mirr8Wg22cHm2TX_pgLptw7fPQ5h9tdOsVTL4gufP5lbsK-ZSc7_LBnb-vi6VOULPSLq6dT_ezO63uk32wW4-zL29efz59V5x9eLs4rc8KwzEeCylsZQXlWlaoFag0JcWUtpSbxkpcVpIjbGxbSksrLumS0sZQLRAjFh54P86ebfddx_BtsmlUg0vG9r32NkxJCcYpgsry_5JCixIRDvLJX_IiTNHDMRThjHFWIilBPf6nwpXAjFdiv1Wne6ucb8MYtdk0VjUhDPOKMARqfoOC0djBmeBt6-D7QcHzgwIwo_0-dnpKSS0-nR_akz_syup-XKXQT6MLPh3CF1toYkgp2latoxt0_KEwUptsqW5Um2wpyBboR7vjT0tIzG_7K0wAnu6ATkb3bdTeuLR3pOQYLhLcy61L8Mt3Nu7v8aa-PwE5wNzN</recordid><startdate>20100401</startdate><enddate>20100401</enddate><creator>Georgiadis, A</creator><creator>Tschernutter, M</creator><creator>Bainbridge, J W B</creator><creator>Robbie, S J</creator><creator>McIntosh, J</creator><creator>Nathwani, A C</creator><creator>Smith, A J</creator><creator>Ali, R R</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>7QO</scope></search><sort><creationdate>20100401</creationdate><title>AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins</title><author>Georgiadis, A ; Tschernutter, M ; Bainbridge, J W B ; Robbie, S J ; McIntosh, J ; Nathwani, A C ; Smith, A J ; Ali, R R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c611t-97e8e736a980f705c53133f36cde91589601cef59e38693b33dc3a7042e0423b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Alleles</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Applied cell therapy and gene therapy</topic><topic>Base Pairing</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Blotting, Western</topic><topic>Care and treatment</topic><topic>Cell Biology</topic><topic>Cellular biology</topic><topic>Dependovirus</topic><topic>Dependoviruses</topic><topic>Development and progression</topic><topic>DNA Primers - genetics</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression</topic><topic>Gene silencing</topic><topic>Gene Therapy</topic><topic>Genetic aspects</topic><topic>Genetic Therapy - methods</topic><topic>Health aspects</topic><topic>Health. Pharmaceutical industry</topic><topic>Human Genetics</topic><topic>Immunohistochemistry</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Intermediate Filament Proteins - genetics</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Methods</topic><topic>Mice</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>miRNA</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Nanotechnology</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>original-article</topic><topic>Peripherin</topic><topic>Peripherins</topic><topic>Photoreceptors</topic><topic>Physiological aspects</topic><topic>Properties</topic><topic>Retina</topic><topic>Retinal degeneration</topic><topic>Retinal Degeneration - genetics</topic><topic>Retinal Degeneration - therapy</topic><topic>Retinal diseases</topic><topic>Retinitis</topic><topic>Retinitis pigmentosa</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA Interference</topic><topic>RNA-mediated interference</topic><topic>Synthesis</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Georgiadis, A</creatorcontrib><creatorcontrib>Tschernutter, M</creatorcontrib><creatorcontrib>Bainbridge, J W B</creatorcontrib><creatorcontrib>Robbie, S J</creatorcontrib><creatorcontrib>McIntosh, J</creatorcontrib><creatorcontrib>Nathwani, A C</creatorcontrib><creatorcontrib>Smith, A J</creatorcontrib><creatorcontrib>Ali, R R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><jtitle>Gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Georgiadis, A</au><au>Tschernutter, M</au><au>Bainbridge, J W B</au><au>Robbie, S J</au><au>McIntosh, J</au><au>Nathwani, A C</au><au>Smith, A J</au><au>Ali, R R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins</atitle><jtitle>Gene therapy</jtitle><stitle>Gene Ther</stitle><addtitle>Gene Ther</addtitle><date>2010-04-01</date><risdate>2010</risdate><volume>17</volume><issue>4</issue><spage>486</spage><epage>493</epage><pages>486-493</pages><issn>0969-7128</issn><eissn>1476-5462</eissn><abstract>Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 (
Prph2
, also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence
Prph2
in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence
Prph2 in vivo
as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>20010626</pmid><doi>10.1038/gt.2009.162</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0969-7128 |
ispartof | Gene therapy, 2010-04, Vol.17 (4), p.486-493 |
issn | 0969-7128 1476-5462 |
language | eng |
recordid | cdi_proquest_miscellaneous_746306935 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Alleles Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Applied cell therapy and gene therapy Base Pairing Base Sequence Biological and medical sciences Biomedical and Life Sciences Biomedicine Biotechnology Blotting, Western Care and treatment Cell Biology Cellular biology Dependovirus Dependoviruses Development and progression DNA Primers - genetics Fundamental and applied biological sciences. Psychology Gene Expression Gene silencing Gene Therapy Genetic aspects Genetic Therapy - methods Health aspects Health. Pharmaceutical industry Human Genetics Immunohistochemistry Industrial applications and implications. Economical aspects Intermediate Filament Proteins - genetics Medical sciences Membrane Glycoproteins - genetics Methods Mice MicroRNAs MicroRNAs - genetics miRNA Molecular Sequence Data Mutation Nanotechnology Nerve Tissue Proteins - genetics original-article Peripherin Peripherins Photoreceptors Physiological aspects Properties Retina Retinal degeneration Retinal Degeneration - genetics Retinal Degeneration - therapy Retinal diseases Retinitis Retinitis pigmentosa Reverse Transcriptase Polymerase Chain Reaction Ribonucleic acid RNA RNA Interference RNA-mediated interference Synthesis Transfusions. Complications. Transfusion reactions. Cell and gene therapy |
title | AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T08%3A41%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AAV-mediated%20knockdown%20of%20Peripherin-2%20in%20vivo%20using%20miRNA-based%20hairpins&rft.jtitle=Gene%20therapy&rft.au=Georgiadis,%20A&rft.date=2010-04-01&rft.volume=17&rft.issue=4&rft.spage=486&rft.epage=493&rft.pages=486-493&rft.issn=0969-7128&rft.eissn=1476-5462&rft_id=info:doi/10.1038/gt.2009.162&rft_dat=%3Cgale_proqu%3EA224168240%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218714687&rft_id=info:pmid/20010626&rft_galeid=A224168240&rfr_iscdi=true |